# SafeBoosC-IIIv - Does Cerebral Oximetry Monitoring Affect Renal Outcomes

> **NCT06926946** · NA · NOT_YET_RECRUITING · sponsor: **St. John's Research Institute** · enrollment: 1000 (estimated)

## Conditions studied

- Acute Renal Failure
- Neonatal Morbidity

## Interventions

- **OTHER:** Intervention Arm- Cerebral Oximetry + Treatment Guideline

## Key facts

- **NCT ID:** NCT06926946
- **Lead sponsor:** St. John's Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07-31
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-09-15
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06926946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06926946, "SafeBoosC-IIIv - Does Cerebral Oximetry Monitoring Affect Renal Outcomes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06926946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*